Upcoming Events
Log In
Pricing
Free Trial

Wk 2, Case 2 - Review

HIDE
PrevNext

0:00

This case does not have a history, but I'm going to

0:03

assume it's a middle-aged older man with an elevated

0:07

PSA, because that's all the cases we're showing here.

0:11

Uh, so this is actually an older case, uh, that was scanned.

0:14

Very early in our experience with, uh, with prostate MRI.

0:19

So we ended up biopsying a bunch of findings

0:21

that we wouldn't have normally biopsied,

0:23

you know, if we were reading the case today,

0:24

because we've learned a lot since that time.

0:26

So it offers some nice correlation on some, on some

0:29

Benign findings that can look worrisome on the MR.

0:33

So it will take the opportunity with this case

0:35

To just go through the thought process of certain

0:37

Lesions and then describe how we handle them now.

0:40

So we've got the axial T2, the axial ADC

0:43

Map, and it's windowed at 1400x1400.

0:46

An interpolated B equals 1600 image.

0:49

And this is a post-contrast image from the

0:51

Dynamics series, but it turns out it's not.

0:53

It's not an arterial phase, it's more of a delayed phase,

0:56

So we, we will not be able to use it all that heavily.

0:59

Um, that's just what happens when you reach

1:00

Into the archives, sometimes you grab, uh, stuff

1:03

That, you look for things that you didn't save

1:05

At the time that you, cause you, you messed up.

1:08

Anyway, um, in the write-up, the first lesion

1:12

Described, and again, I'm gonna go out of order

1:14

So there's parallels with, with the write-up.

1:16

Um, we're looking at the transition zone in

1:18

This case, and we're looking at this right here.

1:27

here's a well-defined, well-circumscribed, so

1:32

circumscribed in the PI-RADS lexicon means it has

1:35

very well-defined borders all the way around.

1:38

Encapsulated means it has an actual dark border,

1:41

rim around it that's separate from the lesion.

1:44

If it's circumscribed, this means well-defined margins.

1:46

So it's well-circumscribed.

1:47

It's T2 dark, okay?

1:49

It's not lenticular-shaped.

1:51

It's not between nodules.

1:53

It actually looks like it's inside of a nodule.

1:56

So based on the characterization,

2:00

this would be a PI-RADS 2.

2:02

The problem is it markedly restricts diffusion.

2:06

If I put an ROI on the ADC map, I'm

2:10

going to get an ADC value in the 600s.

2:13

It's also focally bright on the high B-value image.

2:19

So, if we go to our graph here, it's got a score of 2.

2:25

For T2, it's got a score of 4 for DWI,

2:31

and that makes it a PI-RADS 3 lesion.

2:33

And at that time, we were biopsying, um, all of those,

2:37

and this was biopsied, and it came back as normal tissue.

2:40

Uh, this is kind of the typical

2:42

appearance of a quote, atypical nodule.

2:44

Um, and they're all over the place

2:46

in a lot of transition zones.

2:48

And, I've kind of stopped calling these biopsies,

2:52

biopsyable lesions, mostly because I, the purpose of doing

2:57

the MR is to stop doing biopsy in men who don't need

3:01

biopsies, and these are just way, way, way too common, and it

3:04

almost negates, in my mind, the purpose of doing the MRI.

3:08

Again, what makes me not worry about this being neoplasm

3:12

In a non-pyretic term is that it's inside of a nodule.

3:16

You typically don't get cancers inside nodules.

3:19

They grow between the nodules.

3:20

They push them out of the way.

3:22

There will always be some exceptions,

3:23

but in general, uh, that's, that's true.

3:26

So this is probably what an atypical nodule looks

3:28

Like or some low signal inside of another nodule.

3:30

So that's the first lesion discussed.

3:33

And they're right up.

3:34

The second one is right here,

3:35

Which is in the peripheral zone.

3:37

I'll scroll up and down just a little bit,

3:39

Just to convince you it is the peripheral zone.

3:41

So right here, and we'll find it again on the ADC map.

3:46

So we have a well-defined low T2

3:49

Signal nodule in the peripheral zone.

3:52

Measures less than a centimeter.

3:55

It has corresponding ADC abnormality, right?

3:58

It's focal, it's well-defined, it

4:01

Stands out from the background.

4:03

The ADC value itself is 1183, or almost

4:10

1200, so well above that 1000 cutoff.

4:13

Remember, I set my 1000 cutoff above the recommended

4:16

900 cutoff, so it's well above the cutoff for

4:19

Being like severe, markedly restricted diffusion.

4:23

Um, and it's not bright on the high B value.

4:30

Diffusion in the peripheral zone, right?

4:33

Because it's focal, different from the background,

4:36

But it's not low enough to make a 4 or a 5, right?

4:40

So this is PI-RADS 3.

4:41

If it enhanced in the arterial phase, okay, the PI-RADS 3,

4:47

With enhancement, excuse me, would become a four, right?

4:52

So, if it enhanced the neurotriophage,

4:54

Call it a four, otherwise a three.

4:56

This was biopsied, and it was normal tissue.

5:00

The third lesion, discussed in the write-up,

5:02

Is this one right here in the peripheral zone.

5:06

And to me, this looks like a

5:07

Poorly defined wedge-shaped area

5:10

Of decreased T2 signal.

5:12

And that's the PI-RADS 2 for T2.

5:14

But as we know, it's the diffusion that

5:16

Really counts in the peripheral zone.

5:18

And it markedly restricts diffusion, right?

5:20

So this has an ADC value of 746.

5:25

It's dark on the ADC map.

5:27

And it's actually, I'm gonna find it again, right here.

5:31

It's actually bright.

5:34

Uh, on the high B value.

5:35

So even though it's wedge-shaped, the very

5:37

Low ADC values make this a PI-RADS IV lesion.

5:41

And this is one of the lesions I would

5:43

Hesitate to call a PI-RADS IV lesion.

5:45

Currently, because in my mind, I'm saying wedge-shaped, ill

5:49

Defined on T2, it's gonna be benign, but the ADC is so low,

5:54

You gotta call it a 4, and I was thinking, it's just gonna

5:57

Bring the stats down, and the person doesn't need a biopsy.

6:00

This was biopsied, and uh, most of the cores were negative.

6:04

There was one core with 1 mm of 3 plus 3 disease, I believe

6:09

That's right, um, inside of this Inside of this core.

6:15

Yep.

6:15

So a very small amount of 3 plus 3 disease So either, you

6:21

Know, the biopsy happened to be near an area of low-grade

6:24

Disease or this represents low-grade disease Or the whole

6:29

Thing is low-grade disease and all the other biopsies

6:31

Missed it in that one core You know nicked an edge of it.

6:35

That's almost possible So this is one of those things

6:38

That you are actually going to call a PI-RADS 4 lesion.

Report

CLINICAL INFORMATION

HISTORY
No history provided.

GENERAL ASSESSMENT
PROSTATE METRICS
X (transverse): 7.3 cm
Y (anterior-posterior): 5 cm
Z (craniocaudal): 6.7 cm
Volume: 128.1 cc

T1 ASSESSMENT
A couple of intrinsically T1 hyperintense foci are noted in the right peripheral zone, compatible with hemorrhagic or proteinaceous material.

ZONE ASSESSMENTS
Peripheral zone: Focal lesions as below. The peripheral zone is partially effaced by the enlarged transition zone. There are a few scattered areas of linear/wedge-shaped T2 hypointensity favored to represent prostatitis or its sequela. There are also some small, round encapsulated nodules extending to the peripheral zone from the transition zone, favored to represent small extruded BPH nodules.

Transition zone: A focal lesion is described below. There is marked nodular enlargement of the transition zone, compatible with benign prostatic hyperplasia (BPH) with post-procedural changes compatible with prior transurethral resection of the prostate (TURP).

Central zones: Unremarkable.

Anterior Fibromuscular Stroma: Unremarkable.

Neurovascular bundles: Unremarkable.

Rectoprostatic fat: Unremarkable.

Seminal vesicles: Unremarkable.

Bladder: The bladder is incompletely distended, somewhat limiting its evaluation. Mild diffuse thickening with trabeculations are noted, suspicious for chronic bladder outlet obstruction.

Lymph nodes: No appreciable pelvic lymphadenopathy.

Bone marrow: No suspicious enhancing osseous lesions.

LESIONS
LESION 1: RIGHT ANTERIOR TRANSITION ZONE APICAL MIDGLAND

See Case Review topic for key images of the lesion(s).

SIZE - 1.3 cm x 1 cm in greatest axial dimensions (axial T2 image 22) spanning 1.1 cm in coronal (coronal T2 image 13)

SCORES
Sequence: T2 weighted
Score: 2
Description: Mostly encapsulated nodule

Sequence: Diffusion weighted
Score: 4
Description: Focal markedly hypointense on ADC and markedly hyperintense on high b-value DWI

Sequence: Dynamic contrast enhanced
There are no dynamic contrast enhanced images in this exam, only delayed post contrast.
Score: Dynamic contrast enhancement equivocal

Extracapsular extension - This lesion does not contact the prostate capsule; no evidence of extraprostatic extension.

Total
Score: 3
Description: PIRADS 3: Intermediate (the presence of clinically significant cancer is equivocal)


LESION 2: RIGHT POSTEROMEDIAL PERIPHERAL ZONE APICAL MIDGLAND
See Case Review topic for key images of the lesion(s).
SIZE - 0.5 cm x 0.4 cm in greatest axial dimensions (axial T2 image 21) spanning 0.5 cm in coronal (coronal T2 image 19)

SCORES
Sequence: T2 weighted
Score: 4
Description: Circumscribed, homogenous moderate hypointense focus/mass confined to prostate and less than 1.5 cm in greatest dimension

Sequence: Diffusion weighted
Score: 3
Description: Focal (discrete and different from the background) hypointense on ADC and/or focal hyperintense on high b-value DWI; may be markedly hypointense on ADC or markedly hyperintense on high b-value DWI, but not both.

Sequence: Dynamic contrast enhanced
There are no dynamic contrast enhanced images in this exam, only delayed post contrast.
Score: Dynamic contrast enhancement equivocal

Extracapsular extension - This lesion does not contact the prostate capsule; no evidence of extraprostatic extension.

Total
Score: 3
Description: PIRADS 3: Intermediate (the presence of clinically significant cancer is equivocal)

LESION 3: LEFT POSTEROMEDIAL/POSTEROLATERAL PERIPHERAL ZONE MIDGLAND
See Case Review topic for key images of the lesion(s).
SIZE - 0.6 cm x 0.3 cm in greatest axial dimensions (axial T2 image 21) spanning 0.4 cm in coronal (coronal T2 image 21)

SCORES
Sequence: T2 weighted
Score: 2
Description: Linear or wedge-shaped hypointensity or diffuse mild hypointensity, usually indistinct margin

Sequence: Diffusion weighted
Score: 4
Description: Focal markedly hypontense on ADC and markedly hyperintense on high b-value DWI; <1.5cm in greatest dimension

Sequence: Dynamic contrast enhanced
There are no dynamic contrast enhanced images in this exam, only delayed post contrast.
Score: Dynamic contrast enhancement equivocal

Extracapsular extension - This lesion does not contact the prostate capsule; no evidence of extraprostatic extension.

Total
Score: 3
Description: PIRADS 3: Intermediate (the presence of clinically significant cancer is equivocal)
LESION 4: LEFT POSTEROMEDIAL PERIPHERAL ZONE MIDGLAND
See Case Review topic for key images of the lesion(s).
SIZE - 0.5 cm x 0.5 cm in greatest axial dimensions (axial T2 image 19) spanning 0.5 cm in coronal (coronal T2 image 21)

SCORES
Sequence: T2 weighted
Score: 4
Description: Circumscribed, homogenous moderate hypointense focus/mass confined to prostate and <1.5 cm in greatest dimension

Sequence: Diffusion weighted
Score: 3
Description: Focal (discrete and different from the background) hypointense on ADC and/or focal hyperintense on high b-value DWI; may be markedly hypointense on ADC or markedly hyperintense on high b-value DWI, but not both.

Sequence: Dynamic contrast enhanced
There are no dynamic contrast enhanced images in this exam, only delayed post contrast.
Score: Dynamic contrast enhancement equivocal

Extracapsular extension - This lesion does not contact the prostate capsule; no evidence of extraprostatic extension.

Total
Score: 3
Description: PIRADS 3: Intermediate (the presence of clinically significant cancer is equivocal)

Case Discussion

Faculty

Daniel Cornfeld, MD

Chief Radiologist

Mātai

Stephen J Pomeranz, MD

Chief Medical Officer, ProScan Imaging. Founder, MRI Online

ProScan Imaging

Tags

Prostate/seminal vesicles

MRI

Genitourinary (GU)

© 2025 Medality. All Rights Reserved.

Contact UsTerms of UsePrivacy Policy